Update
FDA approves first US biosimilar from Sandoz
The FDA on Friday morning approved Sandoz’s Zarxio (filgrastim-sndz), the first biosimilar product approved in the US.
Archives for March 6, 2015
CureVac to build plant with Gates Foundation money
CureVac will build a manufacturing facility for mRNA vaccines after a $52m (€46m) Gates Foundation investment that also brings an IPO one step closer according to majority shareholder Dietmar Hopp.
Kite broadens CAR-T manufacturing, research agreement with NCI
Clinical-stage biotech Kite Pharma has broadened its Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).
CDMO Rottendorf signs five new projects with top biopharma companies
Chicago-based Rottendorf Pharmaceuticals, a top 20 contract development and manufacturing organization (CDMO), has signed three formulation development projects and two commercial transfer projects with multiple top pharma and biotech companies in the...